Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis.
Cohen OC, Sharpley F, Gillmore JD, Lachmann HJ, Sachchithanantham S, Mahmood S, Fontana M, Whelan CJ, Martinez-Naharro A, Kyriakou C, Rabin N, Popat R, Yong K, Cheesman S, Shah R, Hawkins PN, Wechalekar AD.
Cohen OC, et al. Among authors: lachmann hj.
Br J Haematol. 2020 May;189(4):643-649. doi: 10.1111/bjh.16401. Epub 2020 Jan 26.
Br J Haematol. 2020.
PMID: 31984481
Free article.